• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疫苗接种会引起针对与地方性冠状病毒刺突蛋白保守表位的不断进化、交叉反应的抗体反应。

COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins.

机构信息

The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

The Translational Genomics Research Institute (TGen), Flagstaff, AZ, USA.

出版信息

Cell Rep. 2022 Jul 5;40(1):111022. doi: 10.1016/j.celrep.2022.111022. Epub 2022 Jun 13.

DOI:10.1016/j.celrep.2022.111022
PMID:35753310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9188999/
Abstract

The COVID-19 pandemic has triggered the first widespread vaccination campaign against a coronavirus. Many vaccinated subjects are previously naive to SARS-CoV-2; however, almost all have previously encountered other coronaviruses (CoVs), and the role of this immunity in shaping the vaccine response remains uncharacterized. Here, we use longitudinal samples and highly multiplexed serology to identify mRNA-1273 vaccine-induced antibody responses against a range of CoV Spike epitopes, in both phylogenetically conserved and non-conserved regions. Whereas reactivity to SARS-CoV-2 epitopes shows a delayed but progressive increase following vaccination, we observe distinct kinetics for the endemic CoV homologs at conserved sites in Spike S2: these become detectable sooner and decay at later time points. Using homolog-specific antibody depletion and alanine-substitution experiments, we show that these distinct trajectories reflect an evolving cross-reactive response that can distinguish rare, polymorphic residues within these epitopes. Our results reveal mechanisms for the formation of antibodies with broad reactivity against CoVs.

摘要

COVID-19 大流行引发了首次针对冠状病毒的广泛疫苗接种运动。许多接种疫苗的受试者以前对 SARS-CoV-2 没有免疫力;然而,几乎所有人以前都曾接触过其他冠状病毒(CoVs),这种免疫在塑造疫苗反应中的作用仍未被描述。在这里,我们使用纵向样本和高度多重化的血清学方法,在 SARS-CoV-2 刺突蛋白的进化保守和非保守区域中,鉴定了 mRNA-1273 疫苗诱导的针对一系列 CoV 刺突表位的抗体反应。虽然对 SARS-CoV-2 表位的反应在接种疫苗后会出现延迟但逐渐增加,但我们观察到 Spike S2 中保守位点的地方性 CoV 同源物的动力学不同:这些同源物更早被检测到,并且在稍后的时间点衰减。使用同源特异性抗体耗竭和丙氨酸取代实验,我们表明这些不同的轨迹反映了一种不断变化的交叉反应性反应,这种反应可以区分这些表位内罕见的多态性残基。我们的研究结果揭示了针对 CoV 形成具有广泛反应性的抗体的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/a0c0fd8eebde/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/99a191d2cdf8/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/822f7369de5a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/e8094a8d6fea/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/cda1804f1bab/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/c8b0e8c3d059/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/a0c0fd8eebde/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/99a191d2cdf8/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/822f7369de5a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/e8094a8d6fea/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/cda1804f1bab/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/c8b0e8c3d059/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/388f/9188999/a0c0fd8eebde/gr5_lrg.jpg

相似文献

1
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins.COVID-19 疫苗接种会引起针对与地方性冠状病毒刺突蛋白保守表位的不断进化、交叉反应的抗体反应。
Cell Rep. 2022 Jul 5;40(1):111022. doi: 10.1016/j.celrep.2022.111022. Epub 2022 Jun 13.
2
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins.新冠病毒疫苗接种可募集并成熟针对地方性冠状病毒刺突蛋白中保守表位的交叉反应性抗体。
medRxiv. 2022 Jan 25:2022.01.24.22269542. doi: 10.1101/2022.01.24.22269542.
3
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
4
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike.SARS-CoV-2 感染而非稳定 Spike 疫苗接种可增强对地方性冠状病毒的交叉反应性抗体
Elife. 2022 Mar 15;11:e75228. doi: 10.7554/eLife.75228.
5
Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens.暴露于 SARS-CoV-2 或接种过疫苗的个体中的抗体反应针对多种 CoV-2 抗原的保守表位。
Int J Mol Sci. 2024 Sep 11;25(18):9814. doi: 10.3390/ijms25189814.
6
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
7
Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination.感染和接种 SARS-CoV-2 刺突蛋白后针对保守表位产生的交叉反应性抗体。
Sci Rep. 2022 Apr 20;12(1):6496. doi: 10.1038/s41598-022-10230-y.
8
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells.非交叉反应表位主导 COVID-19 疫苗接种的体液免疫反应 - 血浆抗体、浆母细胞和记忆 B 细胞的动力学。
Front Immunol. 2024 May 14;15:1382911. doi: 10.3389/fimmu.2024.1382911. eCollection 2024.
9
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.mRNA-1273 疫苗诱导对 SARS-CoV-2 的交叉变体抗体反应,具有预先存在免疫个体和无预先存在免疫个体的不同特征。
Front Immunol. 2021 Sep 3;12:737083. doi: 10.3389/fimmu.2021.737083. eCollection 2021.
10
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.SARS-CoV-2 mRNA 疫苗在未感染人群和既往感染者中诱导出强烈的特异性和交叉反应性 IgG 以及不均等的中和抗体。
Cell Rep. 2022 Feb 1;38(5):110336. doi: 10.1016/j.celrep.2022.110336. Epub 2022 Jan 20.

引用本文的文献

1
PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development.肽序列分析作为一种用于类鼻疽抗原发现和疫苗开发的高度多重化平台。
Front Immunol. 2025 Jul 3;16:1605758. doi: 10.3389/fimmu.2025.1605758. eCollection 2025.
2
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).人类季节性冠状病毒免疫的年龄差异以及ChAdOx1 nCoV-19(AZD1222)的免疫原性。
EBioMedicine. 2025 Jul 16;118:105847. doi: 10.1016/j.ebiom.2025.105847.
3
Mapping disparities in viral infection rates using highly multiplexed serology.

本文引用的文献

1
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.川崎病和儿童 COVID-19 中的 SARS-CoV-2 免疫谱。
Nat Immunol. 2021 Nov;22(11):1452-1464. doi: 10.1038/s41590-021-01051-8. Epub 2021 Oct 5.
2
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.具有有限的新冠病毒交叉反应性的季节性冠状病毒特异性B细胞在重症新冠病毒肺炎中主导IgG反应。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI150613.
3
Cross-reactive CD4 T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
利用高度多重化血清学技术绘制病毒感染率的差异图谱。
mSphere. 2024 Sep 25;9(9):e0012724. doi: 10.1128/msphere.00127-24. Epub 2024 Aug 20.
4
Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein.增强对刺突蛋白内交叉反应性抗原决定簇的评估。
Int J Mol Sci. 2024 Jul 26;25(15):8180. doi: 10.3390/ijms25158180.
5
COVID-19 Vaccination and Parent-Reported Symptomatic Child Asthma Prevalence.新冠病毒疫苗接种与家长报告的有症状儿童哮喘患病率
JAMA Netw Open. 2024 Jul 1;7(7):e2419979. doi: 10.1001/jamanetworkopen.2024.19979.
6
Molecular and physiological changes in the SpaceX Inspiration4 civilian crew.SpaceX 灵感 4 平民机组的分子和生理变化。
Nature. 2024 Aug;632(8027):1155-1164. doi: 10.1038/s41586-024-07648-x. Epub 2024 Jun 11.
7
Cross-Reactive Antibody Responses to Coronaviruses Elicited by SARS-CoV-2 Infection or Vaccination.SARS-CoV-2 感染或接种疫苗引起的冠状病毒交叉反应性抗体反应。
Influenza Other Respir Viruses. 2024 May;18(5):e13309. doi: 10.1111/irv.13309.
8
Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects.刺突蛋白 D796 上的 SARS-CoV-2 反复突变可逃避来自奥密克戎感染康复者和接种疫苗者的抗体。
Microbiol Spectr. 2024 Feb 6;12(2):e0329123. doi: 10.1128/spectrum.03291-23. Epub 2024 Jan 8.
9
Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents.深度免疫球蛋白库测序描绘了 COVID-19 康复者中共享的刺突特异性抗体谱系的综合图谱。
Emerg Microbes Infect. 2024 Dec;13(1):2290841. doi: 10.1080/22221751.2023.2290841. Epub 2024 Jan 24.
10
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.疫苗设计的最新进展:从活疫苗到重组毒素疫苗。
Toxins (Basel). 2023 Sep 8;15(9):563. doi: 10.3390/toxins15090563.
交叉反应性 CD4 T 细胞增强了感染和接种 SARS-CoV-2 后的免疫反应。
Science. 2021 Oct 8;374(6564):eabh1823. doi: 10.1126/science.abh1823.
4
Broad betacoronavirus neutralization by a stem helix-specific human antibody.广谱β冠状病毒通过茎螺旋特异性人抗体中和。
Science. 2021 Sep 3;373(6559):1109-1116. doi: 10.1126/science.abj3321. Epub 2021 Aug 6.
5
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
6
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.SARS-CoV-2 mRNA 疫苗接种诱导针对 NTD、RBD 和 S2 的具有不同功能的抗体。
Cell. 2021 Jul 22;184(15):3936-3948.e10. doi: 10.1016/j.cell.2021.06.005. Epub 2021 Jun 8.
7
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.SARS-CoV-2 mRNA 疫苗可诱导持久的人体生发中心反应。
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.
8
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.SARS-CoV-2 感染后 B 细胞免疫优势分析揭示了针对非中和性病毒靶点的抗体进化。
Immunity. 2021 Jun 8;54(6):1290-1303.e7. doi: 10.1016/j.immuni.2021.05.001. Epub 2021 May 6.
9
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.血清中和抗体及记忆 B 细胞对 SARS-CoV-2 刺突蛋白和地方性冠状病毒感染的交叉反应性。
Nat Commun. 2021 May 19;12(1):2938. doi: 10.1038/s41467-021-23074-3.
10
Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2.对 SARS-CoV-2 的 CD4 T 细胞反应的免疫优势和交叉反应性进行克隆分析。
Science. 2021 Jun 18;372(6548):1336-1341. doi: 10.1126/science.abg8985. Epub 2021 May 18.